Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA does not grant orphan drug status to Levulan PDT for SCC prevention

Aug. 9, 2010

Glycotope begins phase I trial of GT-MAb 5.2-GEX in cancer

Aug. 9, 2010

Clavis advances phase II gemcitabine elaidate trial in pancreatic cancer

Aug. 9, 2010

Italian scientists identify new EGFR inhibitors

Aug. 9, 2010

Cornerstone Pharma adds new site for phase I/II CPI-613 trials in cancer

Aug. 9, 2010

Tekmira files IND application with FDA for PLK1-SNALP in solid tumors

Aug. 6, 2010

NIH provides grant for phase I/II AEZS-108 trial in advanced prostate cancer

Aug. 6, 2010

FDA approves new docetaxel injection concentrate formulation for cancer

Aug. 6, 2010

Gemin X secures funding for obatoclax development

Aug. 6, 2010

Bristol-Myers Squibb claims new JAK2 inhibitors

Aug. 6, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...